Fig. 3
a CLSM images of HepG2 cells treated with Fe-miR122-Cy5/DOX for different time. b and c Fluorescent intensity of DOX and miR122-Cy5 signals across 60-μm regions marked with arrows is shown in line plots
Fig. 3 | Cancer Nanotechnology